期刊文献+

枳实白芍提取物配伍主成分的肠吸收变化研究 被引量:4

Intestinal absorption of main components in the extracts from Aurantii immaturus Fructus and Paeoniae Radix
下载PDF
导出
摘要 目的以枳实和白芍中主要活性成分柚皮苷和芍药苷为指标,考察枳实提取物和白芍提取物配伍后这两种成分在大鼠肠道中的吸收情况。方法采用大鼠在体肠灌流模型,应用超高效液相色谱(UPLC)测定枳实白芍提取物配伍后柚皮苷和芍药苷在肠道吸收的变化量。结果枳实提取物中柚皮苷在十二指肠、空肠、回肠和结肠的吸收率分别为6.18%、5.47%、4.64%、5.12%,白芍提取物中芍药苷在上述四个肠段的吸收率分别为8.08%、7.42%、7.13%、6.66%。结论枳实白芍配伍后柚皮苷和芍药苷与单独提取的提取物相比在大鼠肠道的吸收并未发生显著变化。 AIM To investigate the rat intestinal absorption and interaction of two bioactive components,naringin and paeoniflorin in the extracts of Aurantii immaturus Fructus and Paeoniae Radix.METHODS The rat enteroclysis model was employed and the concentration of naringin and paeoniflorin in intestinal samples were determined by Ultra Performance LC.RESULTS The percent absorption of naringin in its extract was 6.18%,5.47%,4.64% and 5.12% in duodenum,jejunum,ileum and colon in rats,whereas the percent absorption of paeoniflorin in its extract was 8.08%,7.42%,7.13% and 6.66% in rats,respectively.CONCLUSION The absorption of naringin and paeoniflorin in intestine has no significant difference between single extract and the mixture of two extracts.
出处 《中成药》 CAS CSCD 北大核心 2011年第5期791-795,共5页 Chinese Traditional Patent Medicine
基金 国家中医药管理局中医药科学技术研究专项(06-07ZP18) 江苏省中医药领军人才项目(陈彦2009)
关键词 枳实 白芍 吸收 柚皮苷 芍药苷 在体肠灌流模型 Aurantii immaturus Fructus Paeoniae Radix absorption naringin paeoniflorin in situ perfused rat intestinal model
  • 相关文献

参考文献11

二级参考文献74

共引文献359

同被引文献64

  • 1于萍,李克.使用Microsoft Excel进行数据的灰关联分析[J].微型电脑应用,2011(3):29-30. 被引量:66
  • 2王惠洁,杨蓉,林棋.四逆散对小鼠小肠推进功能的影响[J].山西中医学院学报,2007,8(1):17-18. 被引量:5
  • 3陈萌,张冬梅,韦兰兰.枳实芍药散对大鼠肠道高敏性的影响[J].中国实验方剂学杂志,2007,13(6):49-52. 被引量:9
  • 4ZHANG L Y, YANG Z S, ZHANG T, et al. The intestinal micro flora in traditional Chinese medicine compounds metabolism research progress[J].中药材, 2011,34(7): 1155-1158.
  • 5YANG H L, TIAN H, LI P B, et al. Studies on biological activityof naringin and naringenin[J]. J Chin Med Mater(9=' ;f-f), 2007, 30(6): 752-754.
  • 6BANSAL T, A W ASTHI A, JAGGI M, et al. Pre-clinical evidence for altered absorption and biliary excretion of irinotecan (CPT-II) in combination with quercetin: possible contribution of P-glycoprotein[J]. Life Sci, 2008, 83(7/8): 250-259.
  • 7PARK H S, OH J H, LEE J, et al. Minor effects of the citrus flavonoids naringin, naringenin and quercetin, on the pharmacokinetics of doxorubicin in rats[J]. Pharmazie, 2011, 66(6): 424-429.
  • 8NAIT CHABANE M, Al AHMAD A, PELUSO J, et al. Quercetin and naringenin transport across human intestinal Caco-2 cells[J]. J Pharm Pharmacol, 2009, 61(11): 1473-1483.
  • 9LIU Y, HU M. Absorption and metabolism of flavonoids in the Caco-2 cell culture model and a perused rat intestinal model[J]. Drug Metab Dispos, 2002, 30(4): 370-377.
  • 10Bouin M, Plourde V, Boivin M, et al. Rectal distention testing in patients with irritable bowel syndrome: sensitivity, specificity, and predictive values of pain sensory thresholds [J]. Gastroenterology, 2002, 122 (7): 1771.

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部